[Chronic inflammatory bowel diseases. Proven and innovative in the treatment].
D000284:Administration, Oral; D000285:Administration, Rectal; D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage / Q000627:therapeutic use; D001241:Aspirin / Q000008:administration & dosage / Q000627:therapeutic use; D017322:Clinical Trials, Phase II as Topic; D003093:Colitis, Ulcerative / Q000188:drug therapy / Q000628:therapy*; D003424:Crohn Disease / Q000188:drug therapy / Q000276:immunology / Q000628:therapy*; D006801:Humans; D019804:Mesalamine / Q000008:administration & dosage / Q000627:therapeutic use; D010713:Phosphatidylcholines / Q000627:therapeutic use; D010865:Pilot Projects; D017410:Practice Guidelines as Topic; D012074:Remission Induction; D016896:Treatment Outcome; D014258:Trichuris / Q000276:immunology
D000894:Anti-Inflammatory Agents, Non-Steroidal; D010713:Phosphatidylcholines; D019804:Mesalamine; D001241:Aspirin